47 related articles for article (PubMed ID: 1578375)
1. K562 leukemia cells express P2T (adenosine diphosphate) purinergic receptors.
Murgo AJ; Sistare FD
J Pharmacol Exp Ther; 1992 May; 261(2):580-5. PubMed ID: 1578375
[TBL] [Abstract][Full Text] [Related]
2. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
[TBL] [Abstract][Full Text] [Related]
3. Activation of protein kinase C inhibits ATP-induced [Ca2+]i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways.
Gallinaro BJ; Reimer WJ; Dixon SJ
J Cell Physiol; 1995 Mar; 162(3):305-14. PubMed ID: 7860638
[TBL] [Abstract][Full Text] [Related]
4. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
Yen A; Varvayanis S; Platko JD
Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
[TBL] [Abstract][Full Text] [Related]
5. Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.
Murgo AJ; Contrera JG; Sistare FD
Blood; 1994 Mar; 83(5):1258-67. PubMed ID: 8118030
[TBL] [Abstract][Full Text] [Related]
6. Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells.
Vegesna RV; Wu HL; Mong S; Crooke ST
Mol Pharmacol; 1988 May; 33(5):537-42. PubMed ID: 2835653
[TBL] [Abstract][Full Text] [Related]
7. ADP and ATP activate distinct signaling pathways in human promonocytic U-937 cells differentiated with 1,25-dihydroxy-vitamin D3.
Ventura MA; Thomopoulos P
Mol Pharmacol; 1995 Jan; 47(1):104-14. PubMed ID: 7838119
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
Berg KA; Clarke WP; Chen Y; Ebersole BJ; McKay RD; Maayani S
Mol Pharmacol; 1994 May; 45(5):826-36. PubMed ID: 8190100
[TBL] [Abstract][Full Text] [Related]
9. P2U-purinergic receptors on C6-2B rat glioma cells: modulation of cytosolic Ca2+ and cAMP levels by protein kinase C.
Munshi R; DeBernardi MA; Brooker G
Mol Pharmacol; 1993 Dec; 44(6):1185-91. PubMed ID: 8264555
[TBL] [Abstract][Full Text] [Related]
10. Intracellular signalling by nucleotide receptors in PC12 pheochromocytoma cells.
Raha S; de Souza LR; Reed JK
J Cell Physiol; 1993 Mar; 154(3):623-30. PubMed ID: 8436608
[TBL] [Abstract][Full Text] [Related]
11. Characterization of P2 purinergic receptors on human erythro leukemia cells.
Akbar GK; Dasari VR; Sheth SB; Ashby B; Mills DC; Kunapuli SP
J Recept Signal Transduct Res; 1996; 16(3-4):209-24. PubMed ID: 8897312
[TBL] [Abstract][Full Text] [Related]
12. Receptor specific for certain nucleotides stimulates inositol phosphate metabolism and Ca2+ fluxes in A431 cells.
Gonzalez FA; Alfonzo RG; Toro JR; Heppel LA
J Cell Physiol; 1989 Dec; 141(3):606-17. PubMed ID: 2592429
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
Johnson JA; Friedman J; Halligan RD; Birnbaumer M; Clark RB
Mol Pharmacol; 1991 Oct; 40(4):539-46. PubMed ID: 1921986
[TBL] [Abstract][Full Text] [Related]
14. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds.
Okazaki T; Kato Y; Mochizuki T; Tashima M; Sawada H; Uchino H
Exp Hematol; 1988 Jan; 16(1):42-8. PubMed ID: 2826200
[TBL] [Abstract][Full Text] [Related]
15. Presence of functional P2T and P2U purinoceptors on the human megakaryoblastic cell line, Meg-01 characterization by functional and binding studies.
Hechler B; Cazenave JP; Hanau D; Gachet C
Nouv Rev Fr Hematol (1978); 1995; 37(4):231-40. PubMed ID: 8904203
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C activator PMA reduces the Ca(2+) response to antigen stimulation of adherent RBL-2H3 mucosal mast cells by inhibiting depletion of intracellular Ca(2+) stores.
Kuchtey J; Fewtrell C
J Cell Physiol; 1999 Oct; 181(1):113-23. PubMed ID: 10457359
[TBL] [Abstract][Full Text] [Related]
18. [Role of protein kinase C in the regulation of Ca-responses induced by purinergic agonists and thapsigargin in rat peritoneal macrophages].
Krutetskaia ZI; Lebedev OE; Krutetskaia NI
Tsitologiia; 1998; 40(5):445-54. PubMed ID: 9695242
[TBL] [Abstract][Full Text] [Related]
19. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation.
Katz S; Boland R; Santillán G
Int J Biochem Cell Biol; 2006; 38(12):2082-91. PubMed ID: 16893669
[TBL] [Abstract][Full Text] [Related]
20. Phorbol 12-myristate 13-acetate inhibition of leukotriene D4-induced signal transduction was rapidly reversed by staurosporine.
Winkler JD; Sarau HM; Foley JJ; Crooke ST
Biochem Biophys Res Commun; 1988 Dec; 157(2):521-9. PubMed ID: 3202863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
